Home > Journals > Chirurgia > Past Issues > Chirurgia 2017 April;30(2) > Chirurgia 2017 April;30(2):37-9

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE   

Chirurgia 2017 April;30(2):37-9

DOI: 10.23736/S0394-9508.16.04595-2

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Evaluation of a dietary supplement in the treatment of cyclical mastalgia

Chiara ROGANTINI 1, Elena SANTORI 1, Giorgio M. BARATELLI 2

1 Accademia di Senologia, Gravedona ed Uniti, Como, Italia; 2 Ospedale di Gravedona, Gravedona ed Uniti, Como, Italia


PDF


BACKGROUND: Cyclical mastalgia is a common symptom experienced by women of reproductive age; many etiopathogenetic hypothesis have been formulated, and many treatments have been proposed. We tested an anti-inflammatory and anti-edematous dietary supplement, to treat patients with moderate and severe cyclical mastalgia.
METHODS: From June, 2014 to April, 2015, a dietary supplement with anti-inflammatory and anti-edematous properties (Deflogo SD®) was administered to 50 women, 32 with moderate cyclical mastalgia, aged 20-52 (mean age 37), and 18 with severe cyclical mastalgia, aged 28-53 (mean age 42). The study was conducted at the Breast Center of “Delegazione dell’Alto Lario”, of the Lega Italiana per la Lotta contro i Tumori (LILT) of Gravedona (Italy). The weight, height, bra-size, clinical history (number of pregnancies, extent of breast-feeding, usage of oral contraceptives), personal habits (consumption of coffee, physical activity), and breast density of the patients were recorded.
RESULTS: Twelve women dropped out; 38 of 50 patients were evaluated, 26 with moderate and 12 with severe breast pain. The overall response (gathering the cases of reduction with the ones of pain resolution) has been 92.1 %. Women with moderate cyclic breast pain have generally responded better than women with intense cyclic breast pain (96.1% vs.83.3%). Mild collateral effects were observed in 8% of women.
CONCLUSIONS: Our results show that the dietary supplement (Deflogo SD®) is effective and safe to treat patients with moderate or intense cyclical mastalgia.


KEY WORDS: Mastodynia - Breast diseases - Anti-inflammatory agents

top of page